Brainstorm cell therapeutics announces appointment of menghis bairu, md, to board of directors

New york, oct. 28, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, today announced the appointment of menghis bairu, md, to the company's board of directors. the appointment becomes effective on october 28, 20221.

BCLI Ratings Summary

BCLI Quant Ranking